palmidrol has been researched along with Disease Exacerbation in 3 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although subcutaneous administration of interferon (IFN)-β1a is approved as first-line therapy for the treatment of relapsing-remitting MS (RR-MS), its commonly reported adverse events (AEs) such as pain, myalgia, and erythema at the injection site, deeply affect the quality of life (QoL) of patients with MS." | 2.82 | Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis. ( Alhouayek, M; Barbato, F; Calignano, A; Carotenuto, A; Comelli, A; Montella, S; Muccioli, GG; Orefice, G; Orefice, NS, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costagliola, C | 1 |
| Romano, MR | 1 |
| dell'Omo, R | 1 |
| Russo, A | 1 |
| Mastropasqua, R | 1 |
| Semeraro, F | 1 |
| Impellizzeri, D | 1 |
| Bruschetta, G | 1 |
| Ahmad, A | 1 |
| Crupi, R | 1 |
| Siracusa, R | 1 |
| Di Paola, R | 1 |
| Paterniti, I | 1 |
| Prosdocimi, M | 1 |
| Esposito, E | 1 |
| Cuzzocrea, S | 1 |
| Orefice, NS | 1 |
| Alhouayek, M | 1 |
| Carotenuto, A | 1 |
| Montella, S | 1 |
| Barbato, F | 1 |
| Comelli, A | 1 |
| Calignano, A | 1 |
| Muccioli, GG | 1 |
| Orefice, G | 1 |
2 trials available for palmidrol and Disease Exacerbation
| Article | Year |
|---|---|
Effect of palmitoylethanolamide on visual field damage progression in normal tension glaucoma patients: results of an open-label six-month follow-up.
Topics: Adult; Aged; Amides; Disease Progression; Ethanolamines; Female; Follow-Up Studies; Humans; Intraocu | 2014 |
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.
Topics: Administration, Oral; Adult; Amides; Anti-Inflammatory Agents; Cytokines; Disease Progression; Doubl | 2016 |
1 other study available for palmidrol and Disease Exacerbation
| Article | Year |
|---|---|
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion.
Topics: Active Transport, Cell Nucleus; Amides; Animals; Apoptosis; Cell Nucleus; Chymases; Cytokines; Disea | 2015 |